查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029年全球鴉片類藥物使用障礙市場規模研究與預測，按藥物類別、給藥途徑、配銷通路和區域分析。
市場調查報告書
商品編碼
1279081

2022-2029年全球鴉片類藥物使用障礙市場規模研究與預測，按藥物類別、給藥途徑、配銷通路和區域分析。

Global Opioid Use Disorder Market Size study & Forecast, by Drug Class, by Route of Administration, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021年全球鴉片類藥物使用障礙（OUD）市場價值約為28.8億美元，預計在2022-2029年預測期內將以超過8.9%的健康成長率成長。鴉片類藥物是一種鎮痛劑，也能放鬆肌肉、減輕疼痛和緩解壓力。為治療中度至重度疼痛，處方藥包括嗎啡、氫可酮、羥考酮、可待因、芬太尼、美沙酮和其他藥物類鴉片。鴉片類藥物使用障礙（OUD）是一種長期的、復發性的腦部疾病，由過度使用鴉片類藥物定義，儘管有不良影響。它被歸類為一種腦部疾病，因為它涉及到與動機、壓力、自我控制和決策相關的大腦迴路的功能調整，而且這種調整往往在停止使用毒品後持續很長一段時間。鴉片類藥物使用障礙的特點是對鴉片類藥物的強烈渴望，鴉片類藥物耐受性的上升，以及停藥後的戒斷症狀。市場成長的主要驅動因素是，政府和非政府機構越來越重視，包括癌症、心血管疾病和骨科疾病在內的慢性病發病率不斷上升，加上手術干預的發病率激增。

鴉片類藥物成癮病例的增加和相關的後果，使全球的市場需求急劇增加。國家藥物依賴性治療中心（NDDTC）的《印度藥物使用程度》報告指出，2019年2月，目前鴉片類藥物的使用流行率為2.06%，預計約0.55%的印度人需要治療鴉片類藥物使用障礙（有害使用和依賴）。另外，根據美國疾病控制和預防中心，在2020年，美國有近91,799人死於藥物過量。年齡調整後的過量死亡率從2019年的每10萬人21.6人增加到2020年的每10萬人31.1人。 (每10萬人中有28.3人)。因此，上述這些因素成為催化因素，促進市場的大幅成長。此外，鴉片類藥物使用障礙藥物的產品發布和產品批准不斷增加，以及研發活動的投資不斷增加，在預測的幾年裡呈現出各種利潤豐厚的機會。然而，在2022-2029年的預測期內，複雜的報銷結構和OUD藥物的不良反應挑戰市場成長。

全球鴉片類藥物使用障礙（OUD）市場研究考慮的主要地區包括亞太、北美、歐洲、拉美和世界其他地區。北美洲在收入方面占主導地位，因為該地區的政府政策數量不斷增加，同時新產品的推出也在增加。而亞太地區在預測期內也將以最高的複合年成長率成長，原因是鴉片類藥物依賴症患者較多，普通民眾對OUD的認識不斷提高，以及市場空間中的醫療支出不斷增加等因素。

該研究的目的是確定近年來不同領域和國家的市場規模，並對未來幾年的價值進行預測。本報告旨在將該行業的定性和定量方面涵蓋研究範圍內的國家。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球及細分市場的估計和預測
    • 2019-2029年鴉片類藥物使用障礙（OUD）市場，按地區分類
    • 2019-2029年鴉片類藥物使用障礙（OUD）市場，按藥物類別分類
    • 2019-2029年鴉片類藥物使用障礙（OUD）市場，按給藥途徑分類
    • 2019-2029年鴉片類藥物使用障礙（OUD）市場，按配銷通路分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球鴉片類藥物使用障礙（OUD）市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究考慮的年份
  • 貨幣兌換率

第三章：全球鴉片類藥物使用障礙（OUD）市場動態

  • 鴉片類藥物使用障礙（OUD）市場影響分析（2019-2029）。
    • 市場驅動力
      • 政府和非政府機構的關注度不斷提高
      • 鴉片類藥物成癮的案例和相關後果不斷增加
    • 市場挑戰
      • 複雜的報銷結構
      • OUD藥物的不良反應
    • 市場機會
      • 鴉片類藥物使用障礙藥物的產品推出和產品批准不斷增加
      • 對研發活動的投資不斷增加

第四章：全球鴉片類藥物使用障礙（OUD）市場行業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買方的討價還價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 行業專家展望
  • 分析師建議和結論

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球鴉片類藥物使用障礙（OUD）市場，按藥物類別分類

  • 市場簡介
  • 全球鴉片類藥物使用障礙（OUD）市場，按藥物類別，性能-潛力分析
  • 2019-2029年全球鴉片類藥物使用障礙（OUD）市場按藥物類別的估計和預測
  • 鴉片類藥物使用障礙（OUD）市場，細項分析
    • 丁丙諾啡
    • 美沙酮
    • 納曲酮

第7章：全球鴉片類藥物使用障礙（OUD）市場，按給藥途徑分類

  • 市場簡介
  • 全球鴉片類藥物使用障礙（OUD）市場，按給藥途徑，性能-潛力分析
  • 2019-2029年全球鴉片類藥物使用障礙（OUD）市場按給藥途徑的估計和預測
  • 鴉片類藥物使用障礙（OUD）市場，細項分析
    • 口服
    • 腸外

第八章：全球鴉片類藥物使用障礙（OUD）市場，按配銷通路分類

  • 市場簡介
  • 全球鴉片類藥物使用障礙（OUD）市場，按配銷通路分類，業績-潛力分析
  • 2019-2029年全球鴉片類藥物使用障礙（OUD）市場按配銷通路的估計和預測
  • 鴉片類藥物使用障礙（OUD）市場，次級細項分析
    • 醫院藥房
    • 零售藥店和商店
    • 網上藥店

第九章：全球鴉片類藥物使用障礙（OUD）市場，區域分析

  • 鴉片類藥物使用障礙（OUD）市場，區域市場簡介
  • 北美洲
    • 美國
      • 2019-2029年藥物類別細分估計和預測
      • 2019-2029年，給藥途徑的細分估計和預測
      • 2019-2029年配銷通路細分估計和預測
    • 加拿大
  • 歐洲鴉片類藥物使用障礙（OUD）市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區鴉片類藥物使用障礙（OUD）市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲鴉片類藥物使用障礙（OUD）市場簡介
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 世界其他地區

第十章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • MediciNova
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Indivior PLC
    • Alkermes
    • Orexo AB
    • Titan Pharmaceuticals, Inc.
    • Mallinckrodt Pharmaceuticals
    • BioDelivery Sciences International Inc.
    • Viatris Inc. (Mylan NV)
    • Hikma Pharmaceuticals PLC
    • Camurus

第十一章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Opioid Use Disorder (OUD) Market is valued at approximately USD 2.88 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. Opioids are a class of analgesics that also relax muscles, lessen pain, and ease stress. For the treatment of moderate to severe pain, prescriptions are written for drugs including morphine, hydrocodone, oxycodone, codeine, fentanyl, methadone, and other pharmaceutical opioids. Opioid use disorder (OUD) is a long-term, relapsing brain condition defined by excessive opioid use, despite adverse effects. It is classified as a brain condition because it involves functional adjustments to brain circuits associated with motivation, stress, self-control, and decision-making and because such adjustments often last for a long period after drug use has stopped. Opioid use disorder is characterized by an intense desire to take opioids, a rise in opioid tolerance, and withdrawal symptoms following discontinuation. The market growth is primarily driven by the factors such as growing focus of government & non-government institutions, increasing incidences of chronic diseases including cancer, cardiovascular diseases and orthopedic diseases, coupled with the surge in the incidence of surgical intervention.

The rising cases of opioid addiction and related consequences are burgeoning the market demand across the globe. The National Drug Dependence Treatment Centre's (NDDTC) Magnitude of Substance Use in India reported that in February 2019, the prevalence of current opioid use is 2.06%, and approximately 0.55% of Indians are expected to require treatment for opioid use disorders (harmful use and dependence). Also, as per the Centers for Disease Control and Prevention, in 2020, there were nearly 91,799 people died from drug overdoses in the US. Age-adjusted overdose death rates increased from 21.6 per 100,000 in 2019 to 31.1 per 100,000 in 2020. (28.3 per 100,000). Thus, these aforementioned factors are acting as catalyzing factors for market growth at a significant rate. Moreover, the rising product launch and product approval for opioid use disorder drugs, as well as the growing investment in R&D activities are presenting various lucrative opportunities over the forecasting years. However, the complex reimbursement structure and adverse effects of OUD drugs are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Opioid Use Disorder (OUD) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of government policies, along with increasing new product launches in the region. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of patients suffering from opioid dependency, growing awareness amongst the general population regarding OUD, and increasing expenditure on healthcare in the market space.

Major market players included in this report are:

  • MediciNova
  • Indivior PLC
  • Alkermes
  • Orexo AB
  • Titan Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • BioDelivery Sciences International Inc.
  • Viatris Inc. (Mylan N.V.)
  • Hikma Pharmaceuticals PLC
  • Camurus

Recent Developments in the Market:

  • In February 2021, Orexo AB unveiled that the company entered into a collaborative agreement with ApexB.io and Magellan Rx Management in order to do further study on the usage of Modi. This product is a specially designed digital therapeutic for patients with Opioid Use Disorder.

Global Opioid Use Disorder (OUD) Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Route of Administration, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Buprenorphine
  • Methadone
  • Naltrexone

By Route of Administration:

  • Home
  • Dentistry

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies & Stores
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Opioid Use Disorder (OUD) Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Opioid Use Disorder (OUD) Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Opioid Use Disorder (OUD) Market, by Route of Administration, 2019-2029 (USD Billion)
    • 1.2.4. Opioid Use Disorder (OUD) Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Opioid Use Disorder (OUD) Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Opioid Use Disorder (OUD) Market Dynamics

  • 3.1. Opioid Use Disorder (OUD) Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing focus of government & non-government institutions
      • 3.1.1.2. Rising cases of opioid addiction and related consequences
    • 3.1.2. Market Challenges
      • 3.1.2.1. Complex reimbursement structure
      • 3.1.2.2. Adverse effects of OUD drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising product launch and product approval for opioid use disorder drugs
      • 3.1.3.2. Growing investment in the R&D activities

Chapter 4. Global Opioid Use Disorder (OUD) Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Opioid Use Disorder (OUD) Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Opioid Use Disorder (OUD) Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 6.4.1. Buprenorphine
    • 6.4.2. Methadone
    • 6.4.3. Naltrexone

Chapter 7. Global Opioid Use Disorder (OUD) Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Opioid Use Disorder (OUD) Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 7.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Parenteral

Chapter 8. Global Opioid Use Disorder (OUD) Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Opioid Use Disorder (OUD) Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies & Stores
    • 8.4.3. Online Pharmacies

Chapter 9. Global Opioid Use Disorder (OUD) Market, Regional Analysis

  • 9.1. Opioid Use Disorder (OUD) Market, Regional Market Snapshot
  • 9.2. North America Opioid Use Disorder (OUD) Market
    • 9.2.1. U.S. Opioid Use Disorder (OUD) Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Opioid Use Disorder (OUD) Market
  • 9.3. Europe Opioid Use Disorder (OUD) Market Snapshot
    • 9.3.1. U.K. Opioid Use Disorder (OUD) Market
    • 9.3.2. Germany Opioid Use Disorder (OUD) Market
    • 9.3.3. France Opioid Use Disorder (OUD) Market
    • 9.3.4. Spain Opioid Use Disorder (OUD) Market
    • 9.3.5. Italy Opioid Use Disorder (OUD) Market
    • 9.3.6. Rest of Europe Opioid Use Disorder (OUD) Market
  • 9.4. Asia-Pacific Opioid Use Disorder (OUD) Market Snapshot
    • 9.4.1. China Opioid Use Disorder (OUD) Market
    • 9.4.2. India Opioid Use Disorder (OUD) Market
    • 9.4.3. Japan Opioid Use Disorder (OUD) Market
    • 9.4.4. Australia Opioid Use Disorder (OUD) Market
    • 9.4.5. South Korea Opioid Use Disorder (OUD) Market
    • 9.4.6. Rest of Asia Pacific Opioid Use Disorder (OUD) Market
  • 9.5. Latin America Opioid Use Disorder (OUD) Market Snapshot
    • 9.5.1. Brazil Opioid Use Disorder (OUD) Market
    • 9.5.2. Mexico Opioid Use Disorder (OUD) Market
    • 9.5.3. Rest of Latin America Opioid Use Disorder (OUD) Market
  • 9.6. Rest of The World Opioid Use Disorder (OUD) Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. MediciNova
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Indivior PLC
    • 10.2.3. Alkermes
    • 10.2.4. Orexo AB
    • 10.2.5. Titan Pharmaceuticals, Inc.
    • 10.2.6. Mallinckrodt Pharmaceuticals
    • 10.2.7. BioDelivery Sciences International Inc.
    • 10.2.8. Viatris Inc. (Mylan N.V.)
    • 10.2.9. Hikma Pharmaceuticals PLC
    • 10.2.10. Camurus

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Opioid Use Disorder (OUD) Market, report scope
  • TABLE 2. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 5. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Opioid Use Disorder (OUD) Market
  • TABLE 71. List of primary sources, used in the study of global Opioid Use Disorder (OUD) Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Opioid Use Disorder (OUD) Market, research methodology
  • FIG 2. Global Opioid Use Disorder (OUD) Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Opioid Use Disorder (OUD) Market, key trends 2021
  • FIG 5. Global Opioid Use Disorder (OUD) Market, growth prospects 2022-2029
  • FIG 6. Global Opioid Use Disorder (OUD) Market, porters 5 force model
  • FIG 7. Global Opioid Use Disorder (OUD) Market, pest analysis
  • FIG 8. Global Opioid Use Disorder (OUD) Market, value chain analysis
  • FIG 9. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Opioid Use Disorder (OUD) Market, regional snapshot 2019 & 2029
  • FIG 15. North America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Opioid Use Disorder (OUD) Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable